Bioventus SVP exercises RSUs, withholds shares for tax

Bioventus Inc. senior vice president and chief compliance officer Katrina J. Church exercised restricted stock units and received Class A common shares.

Rhea-AI Filing Summary

Bioventus Inc. senior vice president and chief compliance officer Katrina J. Church exercised restricted stock units and received Class A common shares. On February 15, 2026, 4,375 restricted stock units were converted, resulting in 4,375 shares of Class A common stock. A separate transaction shows 2,133 Class A shares were disposed of at $8.27 per share to cover tax obligations tied to this equity award. After these transactions, she directly holds 57,799 shares of Class A common stock and 8,750 restricted stock units. Each restricted stock unit represents a contingent right to one Class A share and vests in four equal installments on each of the first four anniversaries of February 15, 2024, assuming she continues in service.

Insider Trade Summary

4,375 shares exercised/converted

Exercise 3 txns

Insider CHURCH KATRINA J

Role SVP & Chief Compliance Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	4,375	$0.00	$0.00
Exercise	Class A Common Stock	4,375	$0.00	$0.00
Exercise Price or Tax Liability	Class A Common Stock	2,133	$8.27	$18K

Holdings After Transaction: Restricted Stock Units — 8,750 contracts (Direct); Class A Common Stock — 57,799 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
2. F2. The RSU vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bioventus (BVS) report for Katrina J. Church?

Bioventus reported that Katrina J. Church exercised 4,375 restricted stock units into Class A common stock. A related transaction disposed of 2,133 Class A shares to satisfy tax obligations associated with this equity award, all dated February 15, 2026.

How many Bioventus (BVS) shares does Katrina J. Church hold after this Form 4?

After the reported transactions, Katrina J. Church directly holds 57,799 shares of Bioventus Class A common stock. She also holds 8,750 restricted stock units, each representing a contingent right to receive one additional Class A share upon vesting.

What was the purpose of the 2,133-share disposition in Bioventus (BVS) stock?

The 2,133 Bioventus Class A shares were disposed of to pay tax liabilities related to the equity award. The transaction used a price of $8.27 per share, reflecting a tax-withholding mechanism rather than an open-market sale for investment purposes.

How do the restricted stock units for Bioventus (BVS) SVP vest over time?

The restricted stock units vest in four equal installments on each of the first four anniversaries of February 15, 2024. Vesting is conditioned on Katrina J. Church continuing in service with Bioventus through each applicable vesting date.

What does each restricted stock unit (RSU) of Bioventus (BVS) represent?

Each Bioventus restricted stock unit represents a contingent right to receive one share of Class A common stock. Actual share delivery occurs as the units vest, subject to continued service and the vesting schedule specified in the award terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 06:29 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHURCH KATRINA J

(Last) (First) (Middle)

4721 EMPEROR BOULEVARD, SUITE 100

(Street)

DURHAM NC 27703

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bioventus Inc. [ BVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chief Compliance Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/15/2026		M		4,375	A	$0	59,932	D
Class A Common Stock	02/15/2026		F		2,133	D	$8.27	57,799	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/15/2026		M			4,375	(2)	(2)	Class A Common Stock	4,375	$0	8,750	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. The RSU vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

Remarks:

	/s/ Anthony D'Adamio, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.